Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cationic solid-lipid nanoparticles can efficiently bind and transfect plasmid DNA.

C Olbrich1, U Bakowsky, C M Lehr

  • 1Department of Pharmaceutical Technology, Biopharmacy and Biotechnology, Free University of Berlin, 12169, Berlin, Germany.

Journal of Controlled Release : Official Journal of the Controlled Release Society
|December 6, 2001
PubMed
Summary

Cationic solid-lipid nanoparticles (SLN) modified with EQ1 show promise as effective and safe non-viral gene delivery agents. These SLN-DNA complexes efficiently transfected cells, demonstrating good biocompatibility.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regulation of chemicals demands assessment of risks rather than identification of hazards only.

Archives of toxicology·2026
Same author

Influence of nanocrystal size on the in vivo absorption kinetics of caffeine after topical application.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2021
Same author

In silico prediction of dermal absorption of pesticides - an evaluation of selected models against results from in vitro testing.

SAR and QSAR in environmental research·2019
Same author

Maximum Loaded Amorphous Azithromycin Produced Using the Wetness Impregnation Method with Fractional Steps for Dermal Prophylaxis Against Lyme Disease.

Die Pharmazie·2019
Same author

Azithromycin nanocrystals for dermal prevention of tick bite infections.

Die Pharmazie·2019
Same author

Nanoscaled ultrasound contrast agents for enhanced sonothrombolysis.

Colloids and surfaces. B, Biointerfaces·2018

Area of Science:

  • Nanotechnology
  • Biomaterials Science
  • Gene Delivery

Background:

  • Solid-lipid nanoparticles (SLN) are investigated as potential non-viral gene delivery vectors.
  • Cationic modification is explored to enhance DNA binding and cellular uptake.
  • The development of safe and efficient transfection agents remains a critical challenge in gene therapy.

Purpose of the Study:

  • To evaluate the suitability of cationically modified SLN as a novel transfection agent.
  • To characterize the physicochemical properties and DNA complexation of these SLN.
  • To assess the in vitro cytotoxicity and transfection efficiency of SLN-DNA complexes.

Main Methods:

  • SLN were prepared using hot homogenization with Compritol ATO 888 or paraffin as matrix lipids and EQ1 or cetylpyridinium chloride as cationic charge carriers.

Related Experiment Videos

  • Particle size, zeta potential, and DNA binding were analyzed using dynamic light scattering, zeta potential measurements, and agarose gel electrophoresis.
  • Atomic force microscopy (AFM) was used for complex characterization.
  • Cytotoxicity was assessed via LDH release and WST-1 assays.
  • Transfection efficiency was evaluated in Cos-1 cells using a galactosidase expression plasmid.

    • Main Results:

    • SLN with approximately 100 nm size and +40 mV zeta potential were produced.
    • A specific SLN formulation (SII-13: 4% Compritol, 4% Tween/Span, 1% EQ1) effectively formed stable complexes with DNA, with sizes ranging from 300 to 800 nm.
    • Cationic SLN exhibited low cytotoxicity (LD50 >3 mg/ml and >0.6 mg/ml in cytotoxicity assays).
    • SLN-DNA complexes efficiently transfected Cos-1 cells, with enhanced expression in the presence of chloroquine.

    Conclusions:

    • Cationically modified solid-lipid nanoparticles, particularly those formulated with EQ1, are suitable for DNA complexation and gene delivery.
    • These SLN-DNA complexes demonstrate good biocompatibility and efficient in vitro transfection capabilities.
    • The findings support the potential of EQ1-modified SLN as a promising non-viral gene delivery system.